olympia meds tirzepatide Elevate Eli Lilly's weight loss drug
Description
Los participantes del programa SURPASS lograron reducciones promedio de A1C entre 1.8% y 2.1% para Mounjaro de 5 mg y entre 1.7% y 2.4% para Mounjaro de 10 mg y 15 mg
Regular follow-up should include assessment of weight loss trajectory, tolerability, medication adherence, and renal function if significant GI symptoms occur
The median time to onset for all ADEs was 23 days
Compounded tirzepatide with vitamin B12 is not approved by the FDA and should only be purchased from licensed compounding pharmacies
Tirzepatide is available as a compounded rapid dissolve tablet (RDT) through licensed medical providers
What the evidence doesn't do is promise you'll hit the trial averages
